Riskpilot← Back to searchSign inGet full accessORIFARM NORWAY AS
ASActiveOrg 924595388Sandakerveien 138, 0484 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20205 employees
Revenue 2024
NOK 142M
+4733166567% vs 2023
EBITDA margin
-1301.4%
-1844178% vs 2023
Equity ratio
4.8%
Financial strength
Net profit 2024
NOK 7,6B
+148061% vs 2023
| Revenue | NOK 142M | +4733166567% |
| EBITDA | NOK -1,8B | -1844178% |
| Net profit | NOK 7,6B | +148061% |
| Total assets | NOK 193,4B | +371222% |
| Equity | NOK 9,3B | +5970450% |
| Employees | 5 | — |
Legal name
ORIFARM NORWAY AS
Org number
924595388
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. februar 2020
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og ett styremedlem i fellesskap eller to styremedlemmer i fellesskap.
Company purpose
Industri, handel og annen virksomhet som angår disse formål.
Address
Sandakerveien 138, 0484 Oslo
Phone
+4721696910
Email
info@orifarm.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 916 | 18 083 | 136 672 | 0 | 141 995 |
| Staff expenses | −0 | −367 | −92 | −21 | −0 |
| EBITDA | 12 570 | 16 704 | 136 545 | −100 | −1 847 856 |
| Depreciation & amort. | −20 | −0 | −0 | −0 | −0 |
| EBIT | 12 550 | 16 704 | 136 545 | −100 | −1 847 856 |
| Net financials | 0 | 25 | 597 | 8 727 | 11 741 728 |
| Profit before tax | 12 550 | 16 730 | 137 142 | 8 627 | 9 893 872 |
| Tax | 2 763 | 3 682 | 30 329 | 3 521 | 2 328 358 |
| Net profit | 9 787 | 13 048 | 106 813 | 5 106 | 7 565 514 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 144 | 17 871 | 151 540 | 52 083 | 193 395 986 |
| Equity | 9 817 | 13 986 | 12 799 | 156 | 9 320 327 |
| Long-term debt | 0 | 0 | 21 369 | 15 990 | 143 783 332 |
| Short-term debt | 6 327 | 3 885 | 117 371 | 35 937 | 40 292 329 |
| Total debt | 6 327 | 3 885 | 138 741 | 51 927 | 184 075 661 |
EBITDA margin
-1301.4%
This company
15.8%
Market median
-8337% vs market
20202024
Equity ratio
4.8%
This company
38.2%
Market median
-87% vs market
20202024
Return on equity
81.2%
This company
18.4%
Market median
+341% vs market
20202024
Net profit margin
5328.0%
This company
8.1%
Market median
+65678% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
19.75×
This company
0.62×
Market median
-3085% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SH Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (4) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Chairman | 2021 – 2024 | |
| Chairman | 2024 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Orifarm Group As | Company | 100% | 100% | 2024 |
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ORIFARM NORWAY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sverre Haugen | Chief Executive Officer | 0 companies |
| Mads Fink Eriksen | Board of Directors | 0 companies |
| Håkon Bleken | Board of Directors | 0 companies |
| Hans Carl Bøgh-Sørensen | Chairman | 0 companies |
| Jacob Berg Lucassen | Board of Directors | 0 companies |
| Dennis Dencher | Chairman | 0 companies |
| Thomas Brandhof | Chairman | 0 companies |